Rivazeb combination tablets LD, manufactured by Kowa, contain Pitavastatin calcium hydrate and Ezetimibe. This combination medication is used for hypercholesterolemia, inhibiting cholesterol absorption and reducing its production in the liver, provided as 1 tablet (YJ code: 2189103F1029).
Rivazeb combination tablets LD
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).